FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004668368> ?p ?o ?g. }

• W2004668368 endingPage "589" @default.
• W2004668368 startingPage "583" @default.
• W2004668368 abstract "Extracts of human spleen contain two immunologically distinguishable forms of glucocerebrosidase: form I is precipitable by polyclonal or monoclonal anti-(placental glucocerebrosidase) antibodies, whereas form II is not [Aerts, J. M. F. G., Donker-Koopman, W. E., Van der Vliet, M. F. K., Jonsson, L. M. V., Ginns, E. I., Murray, G. J., Barranger, J. A., Tager, J. M. & Schram, A. W. (1985) Eur. J. Biochem. 150, 565-574]. The proportion of form II glucocerebrosidase was high in extracts of spleen, liver and kidney and low in extracts of brain, placenta and fibroblasts. Furthermore, the proportion of form II enzyme was higher in a detergent-free aqueous extract of spleen than in a Triton X-100 extract of total spleen or splenic membranes. When form II glucocerebrosidase in a splenic extract was separated from form I enzyme by immunoaffinity chromatography and stored at 4 degrees C, a gradual conversion to form I enzyme occurred. The conversion was almost immediate if 30% (v/v) ethylene glycol was present. In the denatured state both forms of glucocerebrosidase reacted with anti-(placental glucocerebrosidase) antibodies. Form I glucocerebrosidase was stimulated by sodium taurocholate or sphingolipid-activator protein 2 (SAP-2), whereas form II enzyme exhibited maximal activity in the absence of the effectors. The pH activity profile of form II glucocerebrosidase was almost identical to that of form I enzyme in the presence of SAP-2. In the native state, form I glucocerebrosidase had a molecular mass of 60 kDa whereas that of form II glucocerebrosidase was about 200 kDa. After gel-permeation high-performance liquid chromatography of splenic extracts, the fractions with form II glucocerebrosidase contained material cross-reacting with both anti-(placental glucocerebrosidase) and anti-(SAP-2) antibodies. Preincubation of form I glucocerebrosidase with SAP-2 at pH 4.5 led to masking of the epitope on glucocerebrosidase reacting with monoclonal anti-(placental glucocerebrosidase) antibody 2C7. Furthermore, preincubation of form I glucocerebrosidase with monoclonal antibody 2C7 prevented activation of the enzyme by SAP-2. We propose that form I glucocerebrosidase is a monomeric form of the enzyme, whereas form II glucocerebrosidase is a high-Mr complex of the enzyme in association with sphingolipid-activator protein 2." @default.
• W2004668368 created "2016-06-24" @default.
• W2004668368 creator A5008321998 @default.
• W2004668368 creator A5013935159 @default.
• W2004668368 creator A5016593142 @default.
• W2004668368 creator A5017791828 @default.
• W2004668368 creator A5021349375 @default.
• W2004668368 creator A5042984916 @default.
• W2004668368 creator A5056157813 @default.
• W2004668368 creator A5061415255 @default.
• W2004668368 creator A5068424405 @default.
• W2004668368 date "1987-03-01" @default.
• W2004668368 modified "2023-10-13" @default.
• W2004668368 title "Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts" @default.
• W2004668368 cites W1529738243 @default.
• W2004668368 cites W1559584802 @default.
• W2004668368 cites W1596557428 @default.
• W2004668368 cites W1601276957 @default.
• W2004668368 cites W1606180605 @default.
• W2004668368 cites W1698158786 @default.
• W2004668368 cites W2001358231 @default.
• W2004668368 cites W2014811468 @default.
• W2004668368 cites W2017112394 @default.
• W2004668368 cites W2019563960 @default.
• W2004668368 cites W2026048118 @default.
• W2004668368 cites W2035814962 @default.
• W2004668368 cites W2038783394 @default.
• W2004668368 cites W2042814328 @default.
• W2004668368 cites W2045529594 @default.
• W2004668368 cites W2054214378 @default.
• W2004668368 cites W2064678211 @default.
• W2004668368 cites W2073693990 @default.
• W2004668368 cites W2077269075 @default.
• W2004668368 cites W2083872026 @default.
• W2004668368 cites W2091628121 @default.
• W2004668368 cites W2093615454 @default.
• W2004668368 cites W2095417315 @default.
• W2004668368 cites W2116046158 @default.
• W2004668368 cites W2124663723 @default.
• W2004668368 cites W2408181277 @default.
• W2004668368 cites W2421761749 @default.
• W2004668368 cites W991181056 @default.
• W2004668368 doi "https://doi.org/10.1111/j.1432-1033.1987.tb10907.x" @default.
• W2004668368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3830174" @default.
• W2004668368 hasPublicationYear "1987" @default.
• W2004668368 type Work @default.
• W2004668368 sameAs 2004668368 @default.
• W2004668368 citedByCount "34" @default.
• W2004668368 countsByYear W20046683682012 @default.
• W2004668368 countsByYear W20046683682015 @default.
• W2004668368 countsByYear W20046683682019 @default.
• W2004668368 crossrefType "journal-article" @default.
• W2004668368 hasAuthorship W2004668368A5008321998 @default.
• W2004668368 hasAuthorship W2004668368A5013935159 @default.
• W2004668368 hasAuthorship W2004668368A5016593142 @default.
• W2004668368 hasAuthorship W2004668368A5017791828 @default.
• W2004668368 hasAuthorship W2004668368A5021349375 @default.
• W2004668368 hasAuthorship W2004668368A5042984916 @default.
• W2004668368 hasAuthorship W2004668368A5056157813 @default.
• W2004668368 hasAuthorship W2004668368A5061415255 @default.
• W2004668368 hasAuthorship W2004668368A5068424405 @default.
• W2004668368 hasBestOaLocation W20046683681 @default.
• W2004668368 hasConcept C153911025 @default.
• W2004668368 hasConcept C159654299 @default.
• W2004668368 hasConcept C181199279 @default.
• W2004668368 hasConcept C185592680 @default.
• W2004668368 hasConcept C203014093 @default.
• W2004668368 hasConcept C2779994418 @default.
• W2004668368 hasConcept C2780674200 @default.
• W2004668368 hasConcept C2780931953 @default.
• W2004668368 hasConcept C28212737 @default.
• W2004668368 hasConcept C55493867 @default.
• W2004668368 hasConcept C71240020 @default.
• W2004668368 hasConcept C86803240 @default.
• W2004668368 hasConcept C956191 @default.
• W2004668368 hasConceptScore W2004668368C153911025 @default.
• W2004668368 hasConceptScore W2004668368C159654299 @default.
• W2004668368 hasConceptScore W2004668368C181199279 @default.
• W2004668368 hasConceptScore W2004668368C185592680 @default.
• W2004668368 hasConceptScore W2004668368C203014093 @default.
• W2004668368 hasConceptScore W2004668368C2779994418 @default.
• W2004668368 hasConceptScore W2004668368C2780674200 @default.
• W2004668368 hasConceptScore W2004668368C2780931953 @default.
• W2004668368 hasConceptScore W2004668368C28212737 @default.
• W2004668368 hasConceptScore W2004668368C55493867 @default.
• W2004668368 hasConceptScore W2004668368C71240020 @default.
• W2004668368 hasConceptScore W2004668368C86803240 @default.
• W2004668368 hasConceptScore W2004668368C956191 @default.
• W2004668368 hasIssue "3" @default.
• W2004668368 hasLocation W20046683681 @default.
• W2004668368 hasLocation W20046683682 @default.
• W2004668368 hasOpenAccess W2004668368 @default.
• W2004668368 hasPrimaryLocation W20046683681 @default.
• W2004668368 hasRelatedWork W146202418 @default.
• W2004668368 hasRelatedWork W1978453396 @default.
• W2004668368 hasRelatedWork W1982567030 @default.
• W2004668368 hasRelatedWork W2018413602 @default.
• W2004668368 hasRelatedWork W2114800281 @default.

• next